Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Yasuo Urata"'
Autor:
Takanori Oyama, Hiroshi Tazawa, Hiroshi Nouso, Yasuo Urata, Takuo Noda, Toshiyoshi Fujiwara, Morimichi Tani, Terutaka Tanimoto, Takeshi Ieda, Shunsuke Kagawa
Publikováno v:
Molecular Therapy: Oncolytics, Vol 18, Iss, Pp 14-23 (2020)
Molecular Therapy Oncolytics
Molecular Therapy Oncolytics
Neuroblastoma (NB) is a primary malignant tumor of the peripheral sympathetic nervous system. High-risk NB is characterized by MYCN amplification and human telomerase reverse transcriptase (hTERT) rearrangement, contributing to hTERT activation and a
Autor:
Kanae Abe, Yasuo Urata, Natsuki Yanase, Hiroyuki Mizuguchi, Akikazu Asada, Hideki Hayakawa, Fuminori Sakurai
Publikováno v:
Biologicalpharmaceutical bulletin. 41(10)
In recent times, oncolytic viruses expressing an extraneous gene have attracted great interest; in fact, they have been engaged in multiple applications, such as medicine for cancer. Our group made an oncolytic adenovirus, namely, OBP-301, for use in
Autor:
Robert M. Hoffman, Shunsuke Kagawa, Hiroshi Tazawa, Michael Bouvet, Shinji Miwa, Hiroyuki Kishimoto, Toshiyoshi Fujiwara, Yasuo Urata, Shuya Yano
Publikováno v:
Journal of Orthopaedic Research. 34:836-844
In a previous study, we developed fluorescence-guided surgery (FGS) for osteosarcoma using an orthotopic model with 143B human osteosarcoma cells expressing red fluorescent protein (RFP) implanted into the intramedullary cavity of the tibia in nude m
Autor:
Michael Bouvet, Hiroyuki Kishimoto, Shuya Yano, Yasuo Urata, Hiroshi Tazawa, Kiyoto Takehara, Toshiyoshi Fujiwara, Robert M. Hoffman, Shunsuke Kagawa
Publikováno v:
In Vitro Cellular & Developmental Biology - Animal. 53:285-287
Autor:
Shuya Yano, Toshiyoshi Fujiwara, Yasuo Urata, Hiroshi Tazawa, Michael Bouvet, Robert M. Hoffman, Shunsuke Kagawa, Kiyoto Takehara, Hiroyuki Kishimoto
Publikováno v:
Cancer Gene Therapy. 24:45-47
We previously described the development of a highly-invasive, triple-negative breast cancer (TNBC) variant using serial orthotopic implantation of MDA-MB-231 human breast cancer in nude mice. The isolated variant is highly invasive in the mammary gla
Autor:
Yuuri Hashimoto, Shuji Nakamura, Toshiyoshi Fujiwara, Yasuhiro Shirakawa, Makoto Takeuchi, Hiroshi Tazawa, Takeshi Otani, Hiroyuki Mizuguchi, Teppei Onishi, Shunsuke Kagawa, Fuminori Sakurai, Hiroyuki Kishimoto, Yuzo Umeda, Yasuo Urata
Publikováno v:
Scientific Reports
“Cell-in-cell” denotes an invasive phenotype in which one cell actively internalizes in another. The novel human T-cell line HOZOT, established from human umbilical cord blood, was shown to penetrate a variety of human cancer cells but not normal
Autor:
Yuuri Hashimoto, Toshiyoshi Fujiwara, Masahiko Nishizaki, Hiroyuki Kishimoto, Hiroshi Tazawa, Shinji Kuroda, Takeshi Nagasaka, Shuya Yano, Yasuo Urata, Futoshi Uno, Yasuhiro Shirakawa, Robert M. Hoffman, Shunsuke Kagawa
Publikováno v:
Clinical Cancer Research. 19(23):6495-6505
Purpose: Because chemoradiotherapy selectively targets proliferating cancer cells, quiescent cancer stem–like cells are resistant. Mobilization of the cell cycle in quiescent leukemia stem cells sensitizes them to cell death signals. However, it is
Autor:
Yasuo Urata, Yuji Kurihara, Seiji Kondo, Daisuke Sato, Toshiyoshi Fujiwara, Satoru Shintani, Tatsuo Shirota
Publikováno v:
Oncology Reports. 30:2659-2664
We evaluated the antitumor effect of a telomerase-specific replication-selective adenovirus (Telomelysin, OBP-301) for adenoid cystic carcinoma (ACC) in vitro and in vivo. Adenovirus E1 gene expression was controlled by human telomerase reverse trans
Autor:
Yasuo Urata, Ryozo Kuwano, Akira Ogose, Toshiyoshi Fujiwara, Gui Dong Li, Takashi Ariizumi, Tetsuo Hotta, Hiroyuki Kawashima, Naoto Endo
Publikováno v:
Cancer Sci
This study investigated the pathway underlying the antitumor activity of telomelysin, a telomerase‐dependent, replication‐selective oncolytic adenovirus, in soft tissue sarcoma cells. Treatment with telomelysin alone resulted in simultaneous indu
Autor:
Yuuri Hashimoto, Shinji Kuroda, Shunsuke Kagawa, Ryosuke Yoshida, Yasuo Urata, Toru Kojima, Futoshi Uno, Yasumoto Yamasaki, Hiroyuki Mizuguchi, Shuya Yano, Akira Ohtsuru, Toshiyoshi Fujiwara, Hiroshi Tazawa
Publikováno v:
European Journal of Cancer. 48:2282-2291
Oncolytic viruses engineered to replicate in tumour cells but not in normal cells could be used as tumour-specific vectors carrying the therapeutic genes. We previously developed a telomerase-specific oncolytic adenovirus, OBP-301, that causes cell d